ProCE Banner Activity

Considerations for PrEP for People Who Inject Drugs

Clinical Thought
Adherence and accessibility are critical to improving uptake and effectiveness of PrEP for PWID.

Released: April 15, 2022

Expiration: April 14, 2023

Share

Faculty

Karine Lacombe

Karine Lacombe, MD, PhD

Professor
UMR-S1136
Sorbonne University
Professor
Head, Infectious Diseases Department
St Antoine Hospital, AP-HP
Paris, France

Supporters

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

ViiV Healthcare

Faculty Disclosure

Primary Author

Karine Lacombe, MD, PhD

Professor
UMR-S1136
Sorbonne University
Professor
Head, Infectious Diseases Department
St Antoine Hospital, AP-HP
Paris, France

Karine Lacombe, MD, PhD, has disclosed that she has received consulting fees from Gilead Sciences, GlaxoSmithKline, Janssen, and MSD.